All leaders have to speak to things that are right and wrong: Former Onyx Pharma CEO

Tony Coles, Yumanity Therapeutics CEO and former Onyx Pharma CEO, discusses the impact of Merck CEO Ken Frazier's leaving President Trump's Manufacturing Council. CNBC's Meg Tirrell weighs in.
Wed, Aug 16 20173:42 PM EST